FdaApplication

ANDA 209715

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMS
application_typeANDA
approval_date2018-10-22

Products (1)

ProductActive ingredientStrengthDosage form
CLOBAZAMCLOBAZAM2.5MG/MLSUSPENSION;ORAL

1 product